Ocuphire Pharma to Present in the BIO CEO & Investor Conference
FARMINGTON HILLS, Mich., Feb. 23, 2024 (GLOBE NEWSWIRE) — Ocuphire Pharma, Inc. (Nasdaq: OCUP) (“Ocuphire”), a clinical-stage ophthalmic biopharmaceutical company […]
FARMINGTON HILLS, Mich., Feb. 23, 2024 (GLOBE NEWSWIRE) — Ocuphire Pharma, Inc. (Nasdaq: OCUP) (“Ocuphire”), a clinical-stage ophthalmic biopharmaceutical company […]
RESTON, Va., Feb. 23, 2024 (GLOBE NEWSWIRE) — Comscore, Inc. (Nasdaq: SCOR), a trusted partner for planning, transacting and evaluating […]
Expanded access program (EAP) data for omidubicel are consistent with Phase 3 trial results on rates of hematopoietic recovery and […]
SIOUX FALLS, S.D., Feb. 23, 2024 (GLOBE NEWSWIRE) — SAB Biotherapeutics, Inc. (Nasdaq: SABS), (“SAB” or the “Company”), a clinical-stage biopharmaceutical […]
PLANO, Texas, Feb. 23, 2024 (GLOBE NEWSWIRE) — Alkami Technology, Inc. (Nasdaq: ALKT) (“Alkami”), a leading cloud-based digital banking solutions […]
TORONTO, Feb. 23, 2024 (GLOBE NEWSWIRE) — Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical […]
VANCOUVER, British Columbia, Feb. 23, 2024 (GLOBE NEWSWIRE) — Dominion Lending Centres Inc. (TSX:DLCG) (“DLCG” or the “Corporation”) is pleased […]
HAMILTON, Bermuda and NEW YORK, Feb. 23, 2024 (GLOBE NEWSWIRE) — Textainer Group Holdings Limited (NYSE: TGH; JSE: TXT) (“Textainer”), […]
NEW YORK, Feb. 23, 2024 (GLOBE NEWSWIRE) — TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that a conference call will […]
VANCOUVER, British Columbia, Feb. 23, 2024 (GLOBE NEWSWIRE) — Brixton Metals Corporation (TSX-V: BBB, OTCQB: BBBXF) (the “Company” or “Brixton”) […]